Cancer Cell Metastasis: The In Vitro Approach

A special issue of Life (ISSN 2075-1729). This special issue belongs to the section "Cell Biology and Tissue Engineering".

Deadline for manuscript submissions: closed (31 March 2022) | Viewed by 2795

Special Issue Editor


E-Mail Website
Guest Editor
Biomedical Sciences Program, Department of Life Sciences, School of Sciences, European University Cyprus, Nicosia 1516, Cyprus
Interests: cancer cell metastasis; in vitro models; adhesion; extracellular matrix; actin cytoskeleton; invasion
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues

Cancer-related mortality is, in most cases, attributed to the effects and complications of cancer cell metastasis and not the primary tumor itself. Metastasis is a complex process during which cells initially dissociate from the original tumor and migrate and invade through the extracellular matrix and surrounding tissues. Subsequently, they are disseminated through the circulation to distant sites of the body, where they form metastatic tumors. Although extensive research has been conducted in the field, several questions remain unanswered. Taking advantage of the new developments in cell culture systems and models, efforts have been made to mimic the metastatic process in vitro in order to better study it, understand it and ultimately reverse it. This Special Issue aims to present these advances in cancer cell metastasis-related research involving in vitro approaches and models that will provide a more thorough understanding of cancer cell metastasis and the cellular and molecular events and mechanisms that define it. The studies may involve culture models and assays developed in two or three dimensions (3D) in any type of cancer cell line and any related molecular signaling pathway that regulates cancer cell adhesion, migration, invasion and proliferation.

Dr. Vasiliki Gkretsi
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Life is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • cancer cell metastasis
  • tumor spheroids
  • 3D culture models
  • in vitro experimentation
  • actin cytoskeleton
  • cell invasion
  • extracellular matrix
  • cell adhesion

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

13 pages, 5459 KiB  
Article
Inhibition of HDACs Suppresses Cell Proliferation and Cell Migration of Gastric Cancer by Regulating E2F5 Targeting BCL2
by Arshad Ali, Ayaz Ali, Shaker Khan, Muhammad Ibrahim, Mohammed Ali Alshehri and Anand Thirupathi
Life 2021, 11(12), 1425; https://doi.org/10.3390/life11121425 - 17 Dec 2021
Cited by 4 | Viewed by 2193
Abstract
(1) Background: Gastric cancer (GC) is the most common high death-rate cancer type worldwide, with an enhanced prevalence and increased rate of mortality. Although significant evidence on surgery strategy has been generated for the treatment of GC, conclusions are still uncertain regarding profound [...] Read more.
(1) Background: Gastric cancer (GC) is the most common high death-rate cancer type worldwide, with an enhanced prevalence and increased rate of mortality. Although significant evidence on surgery strategy has been generated for the treatment of GC, conclusions are still uncertain regarding profound metastatic or persevering gastric cancer. Therefore, it is essential to develop novel and effective biomarkers or therapeutic targets for the diagnosis of GC. Histone deacetylations (HDACs) are important epigenetic regulators that control the aberrant transcription of critical genes that are mainly involved in cell proliferation, cell migration, regulation of the cell cycle, and different signal pathways. (2) Methods: Expression analysis of HDACs family members and E2F5 in gastric cancer cell lines was determined by RT-PCR and Western blotting. The cell proliferation was determined through an MTT assay. Cell migration was determined using a wound-healing assay. Flow cytometry experiments were used to determine cell-cycle analysis. The statistical software OriginPro 2015 (OriginLab, Northampton, MA, USA) was used to analyze data. A p value of < 0.05 was regarded as significant. (3) Results: The present study shows that E2F5 expression is upregulated in GC cancer cell lines compared to normal cell lines, and is positively associated with the level of HDACs and BCL2. HDACi and knocking down of E2F5 as tumor suppressors inhibited cell proliferation, migration invasion, and blocked the cell cycle in gastric cancer cells by suppressing BCL2. The results conclude that the anticancer mechanism of HDACi was determined by regulating E2F5 via targeting BCL2. (4) Conclusions: Our results suggest that the HDAC–E2F5–BCL2 signaling axis might be a novel potential biomarker in gastric cancer. Full article
(This article belongs to the Special Issue Cancer Cell Metastasis: The In Vitro Approach)
Show Figures

Figure 1

Back to TopTop